NYSE:CLB   Core Laboratories N.V
Currently owned at 93% of all outstanding shares by institutional investors and 1.1% of insider investors own shares.

Gross revenue: 668 Million
Price/Sales: 1.93
Net income: +101.98 Million
Earnings per share: $1.79
Price/Earnings: 15.54
Net Margins: -19
% Return on equity: 45
% Return on assets: 6.74
% volatility compared to S&P 500: 238